GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NDatalyze Corp (OTCPK:NDATF) » Definitions » EV-to-EBITDA

NDatalyze (NDatalyze) EV-to-EBITDA : -7.92 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is NDatalyze EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, NDatalyze's enterprise value is $3.24 Mil. NDatalyze's EBITDA for the trailing twelve months (TTM) ended in Nov. 2023 was $-0.41 Mil. Therefore, NDatalyze's EV-to-EBITDA for today is -7.92.

The historical rank and industry rank for NDatalyze's EV-to-EBITDA or its related term are showing as below:

NDATF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -58.63   Med: -5.02   Max: 353.08
Current: -7.92

During the past 5 years, the highest EV-to-EBITDA of NDatalyze was 353.08. The lowest was -58.63. And the median was -5.02.

NDATF's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 13.055 vs NDATF: -7.92

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), NDatalyze's stock price is $0.0933. NDatalyze's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 was $-0.011. Therefore, NDatalyze's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


NDatalyze EV-to-EBITDA Historical Data

The historical data trend for NDatalyze's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDatalyze EV-to-EBITDA Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23
EV-to-EBITDA
- -31.62 -9.78 -5.94 -5.38

NDatalyze Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.52 -5.38 -1.24 -2.77 -10.21

Competitive Comparison of NDatalyze's EV-to-EBITDA

For the Health Information Services subindustry, NDatalyze's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NDatalyze's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where NDatalyze's EV-to-EBITDA falls into.



NDatalyze EV-to-EBITDA Calculation

NDatalyze's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3.239/-0.409
=-7.92

NDatalyze's current Enterprise Value is $3.24 Mil.
NDatalyze's EBITDA for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NDatalyze  (OTCPK:NDATF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

NDatalyze's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0933/-0.011
=At Loss

NDatalyze's share price for today is $0.0933.
NDatalyze's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.011.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


NDatalyze EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of NDatalyze's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


NDatalyze (NDatalyze) Business Description

Traded in Other Exchanges
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.

NDatalyze (NDatalyze) Headlines

From GuruFocus